Hebei Changshan Biochemical Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hebei Changshan Biochemical Pharmaceutical Co Ltd with three other
companies in this sector in China:
Huaren Pharmaceutical Co Ltd
sales of 1.31 billion Chinese Renmimbi [US$191.57 million]
of which 89%
was Medicine Industry),
Yantai Dongcheng Pharmaceutical Group Co Ltd
(1.60 billion Chinese Renmimbi [US$233.01 million]
of which 37%
was Nuclides), and
Asymchem Laboratories Tian Jin Co Ltd
(1.42 billion Chinese Renmimbi [US$207.81 million]
of which 100%
was Pharmaceutical industry).
Hebei Changshan Biochemical Pharmaceutical Co Ltd reported sales of 1.42 billion Chinese Renmimbi (US$207.39 million)
December of 2017.
increase of 27.0%
versus 2016, when the company's sales were 1.12 billion Chinese Renmimbi.
Sales at Hebei Changshan Biochemical Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 147%).
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
266.0% in 2017, from
372,096.42 Chinese Renmimbi to 1.36 million Chinese Renmimbi.